One study showed that mice harboring melanoma tumors expressing AKT1E17K had the highest risk for brain metastasis, an effect mediated by FAK, and thus supporting the rationale for the therapeutic targeting of AKT and/or FAK.53 The pathway may also be activated as a late of selective event in the brain. The gene discussed is AKT1; the disease is melanoma.